<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Interaction between the different types of cells within the islet of Langerhans is vital for adequate control of insulin release </plain></SENT>
<SENT sid="1" pm="."><plain>Once insulin secretion becomes defective, as in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, the most useful drugs to increase insulin release are <z:chebi fb="0" ids="26831">sulfonylureas</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>It is well-known that <z:chebi fb="0" ids="26831">sulfonylureas</z:chebi> block K(ATP) channels, which results in depolarization of the membrane that provokes calcium influx and increases intracellular calcium concentration ([<z:chebi fb="0" ids="29108">Ca2+</z:chebi>]i), which thereby triggers insulin secretion </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:chebi fb="0" ids="35358">sulfonamide</z:chebi> <z:chebi fb="0" ids="4495">diazoxide</z:chebi> produces the opposite effect: it activates K(ATP) channels, resulting in a <z:mp ids='MP_0003059'>decreased insulin secretion</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Despite such evidence, little is known about the effect of <z:chebi fb="0" ids="26831">sulfonylureas</z:chebi> and <z:chebi fb="0" ids="35358">sulfonamides</z:chebi> in non-beta-cells of the islet of Langerhans </plain></SENT>
<SENT sid="5" pm="."><plain>In this article, we describe the effects of <z:chebi fb="0" ids="27999">tolbutamide</z:chebi> and <z:chebi fb="0" ids="4495">diazoxide</z:chebi> on [<z:chebi fb="0" ids="29108">Ca2+</z:chebi>]i in alpha-, beta-, and delta-cells within intact islets of Langerhans </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="27999">Tolbutamide</z:chebi> elicits an increase in [Ca2+li in beta- and delta-cells, regardless of <z:chebi fb="105" ids="17234">glucose</z:chebi> concentrations </plain></SENT>
<SENT sid="7" pm="."><plain>Remarkably, <z:chebi fb="0" ids="27999">tolbutamide</z:chebi> is without effect in alpha-cells </plain></SENT>
<SENT sid="8" pm="."><plain>When <z:chebi fb="0" ids="4495">diazoxide</z:chebi> is applied, <z:chebi fb="105" ids="17234">glucose</z:chebi>-induced [<z:chebi fb="0" ids="29108">Ca2+</z:chebi>]i oscillations in beta- and delta-cells are abolished, whereas [<z:chebi fb="0" ids="29108">Ca2+</z:chebi>]i oscillations in alpha-cells remain unaltered </plain></SENT>
<SENT sid="9" pm="."><plain>Furthermore, the existence of <z:chebi fb="0" ids="26831">sulfonylurea</z:chebi> receptors is demonstrated in beta-cells but not in alpha-cells by using binding of glybenclamide-4,4-difluoro-4-bora-3a,4a-diaza-<z:chebi fb="0" ids="33057">s-indacene</z:chebi> (<z:chebi fb="0" ids="51107">BODIPY</z:chebi>) combined with immunostaining for insulin and glucagon </plain></SENT>
</text></document>